Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

Showing products 1–24 of 28. More products

METOPROLOL TARTRATE

21 general benefit · 3 not a benefit

Other products in the same Health Canada class (C07A, C07AB) — coverage varies; not interchangeable

  • Acebutolol (Sectral): general benefit, Not a benefit
  • Atenolol (Apo-Atenol): general benefit
  • Bisoprolol (Sandoz Bisoprolol Tablets): general benefit, Not a benefit
  • Nebivolol (Bystolic): not a benefit
  • Nadolol (Corgard): general benefit, Not a benefit
  • Propranolol (Inderal-LA): general benefit, Not a benefit

3 more in the class list below

Apo-Metoprolol · DIN 00618632 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Metoprolol · DIN 00618632 Manufacturer: Apotex Inc.; listing date 1996-10-01 Daily cost (source): $0.1248 Health Canada: Marketed since 1984-12-31 · brand APO-METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Metoprolol: Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5818 · Verify on the e-Formulary ↗ (DIN 00618632)

Source record
DIN 00618632: Apo-Metoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id APX Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00618632 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5818
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: resolved shortage (ended 2025-06-26); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00618632
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Metoprolol (Type L) · DIN 00749354 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Metoprolol (Type L) · DIN 00749354 Manufacturer: Apotex Inc.; listing date 1996-10-01 Daily cost (source): $0.1248 Health Canada: Marketed since 1988-12-31 · brand APO-METOPROLOL (TYPE L) · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Metoprolol (Type L): Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8603 · Verify on the e-Formulary ↗ (DIN 00749354)

Source record
DIN 00749354: Apo-Metoprolol (Type L) Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id APX Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00749354 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8603
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: resolved shortage (ended 2025-05-15); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00749354
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp-Metoprolol-L · DIN 02356821 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Metoprolol-L · DIN 02356821 Manufacturer: Jamp Pharma Corporation; listing date 2011-12-15 Daily cost (source): $0.1248 Health Canada: Marketed since 2018-05-04 · brand JAMP-METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp-Metoprolol-L: Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84195 · Verify on the e-Formulary ↗ (DIN 02356821)

Source record
DIN 02356821: Jamp-Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id JPC Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02356821 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84195
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: active shortage (reported 2024-01-12, estimated to end 2026-12-31, last updated 2026-05-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02356821
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Metoprolol · DIN 02350394 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Metoprolol · DIN 02350394 Manufacturer: Sanis Health Inc.; listing date 2016-09-29 Daily cost (source): $0.1248 Health Canada: Marketed since 2014-05-24 · brand METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Metoprolol: Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83560 · Verify on the e-Formulary ↗ (DIN 02350394)

Source record
DIN 02350394: Metoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id SAI Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02350394 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83560
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: active shortage (reported 2025-09-03, last updated 2025-09-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02350394
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Metoprolol-L · DIN 02442124 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Metoprolol-L · DIN 02442124 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2022-06-30 Daily cost (source): $0.1248 Health Canada: Marketed since 2021-09-13 · brand METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Metoprolol-L: Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92648 · Verify on the e-Formulary ↗ (DIN 02442124)

Source record
DIN 02442124: Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id SIV Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02442124 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92648
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: resolved shortage (ended 2025-05-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02442124
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PMS-Metoprolol-L · DIN 02230803 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Metoprolol-L · DIN 02230803 Manufacturer: Pharmascience Inc.; listing date 1998-12-31 Daily cost (source): $0.1248 Health Canada: Marketed since 1998-04-16 · brand PMS-METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Metoprolol-L: Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50067 · Verify on the e-Formulary ↗ (DIN 02230803)

Source record
DIN 02230803: PMS-Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id PMS Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02230803 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50067
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: resolved shortage (ended 2025-08-03); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02230803
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Metoprolol · DIN 00648035 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Metoprolol · DIN 00648035 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $0.1248 Health Canada: Marketed since 2011-01-25 · brand TEVA-METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Metoprolol: Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6611 · Verify on the e-Formulary ↗ (DIN 00648035)

Source record
DIN 00648035: Teva-Metoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id TEV Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00648035 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6611
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: resolved shortage (ended 2025-10-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00648035
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Metoprolol (Uncoated) · DIN 00842648 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Metoprolol (Uncoated) · DIN 00842648 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $0.1248 Health Canada: Marketed since 2011-01-25 · brand TEVA-METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Metoprolol (Uncoated): Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9886 · Verify on the e-Formulary ↗ (DIN 00842648)

Source record
DIN 00842648: Teva-Metoprolol (Uncoated) Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id TEV Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00842648 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9886
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624
Shortage status: resolved shortage (ended 2025-08-27); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00842648
Shortage record checked 2026-09-13T08:10:21.292534+00:00

AA-Metoprolol SR · DIN 02285169 · 100mg · LA tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
AA-Metoprolol SR · DIN 02285169 Manufacturer: A A Pharma Inc.; listing date 2007-11-10 Health Canada: Marketed since 2022-10-13 · brand AA-METOPROLOL SR · ATC C07AB02 METOPROLOL · form Tablet (extended-release) · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Aa pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

AA-Metoprolol SR: Formulary list price $0.2058/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2058 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77067 · Verify on the e-Formulary ↗ (DIN 02285169)

Source record
DIN 02285169: AA-Metoprolol SR Raw flags: chronicUseMed=Y, sec3=Y Item: 240400069; group id 284; item number 0605; lccId None; manufacturer id AAP Source form: LA Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2058; ministry $0.2058 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02285169 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77067
Interchangeable products
Lopresor SR · DIN 00658855 · not recorded
Shortage status: resolved shortage (ended 2025-06-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02285169
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Metoprolol · DIN 00618640 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Metoprolol · DIN 00618640 Manufacturer: Apotex Inc.; listing date 1996-10-01 Daily cost (source): $0.2722 Health Canada: Marketed since 1984-12-31 · brand APO-METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Metoprolol: Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5819 · Verify on the e-Formulary ↗ (DIN 00618640)

Source record
DIN 00618640: Apo-Metoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id APX Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00618640 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5819
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 Metoprolol-L · DIN 02442132 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: resolved shortage (ended 2026-03-19); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00618640
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Metoprolol (Type L) · DIN 00751170 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Metoprolol (Type L) · DIN 00751170 Manufacturer: Apotex Inc.; listing date 1996-10-01 Daily cost (source): $0.2722 Health Canada: Marketed since 1988-12-31 · brand APO-METOPROLOL (TYPE L) · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Metoprolol (Type L): Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8602 · Verify on the e-Formulary ↗ (DIN 00751170)

Source record
DIN 00751170: Apo-Metoprolol (Type L) Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id APX Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00751170 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8602
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol · DIN 00618640 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 Metoprolol-L · DIN 02442132 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: resolved shortage (ended 2025-08-28); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00751170
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp-Metoprolol-L · DIN 02356848 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Metoprolol-L · DIN 02356848 Manufacturer: Jamp Pharma Corporation; listing date 2011-12-15 Daily cost (source): $0.2722 Health Canada: Marketed since 2018-05-04 · brand JAMP-METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp-Metoprolol-L: Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84196 · Verify on the e-Formulary ↗ (DIN 02356848)

Source record
DIN 02356848: Jamp-Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id JPC Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02356848 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84196
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol · DIN 00618640 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 Metoprolol-L · DIN 02442132 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: active shortage (reported 2024-01-12, estimated to end 2026-12-31, last updated 2026-05-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02356848
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Metoprolol · DIN 02350408 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Metoprolol · DIN 02350408 Manufacturer: Sanis Health Inc.; listing date 2016-09-29 Daily cost (source): $0.2722 Health Canada: Marketed since 2014-05-24 · brand METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Metoprolol: Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83561 · Verify on the e-Formulary ↗ (DIN 02350408)

Source record
DIN 02350408: Metoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id SAI Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02350408 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83561
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol · DIN 00618640 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol-L · DIN 02442132 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: anticipated shortage (last updated 2026-05-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02350408
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Metoprolol-L · DIN 02442132 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Metoprolol-L · DIN 02442132 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2022-06-30 Daily cost (source): $0.2722 Health Canada: Marketed since 2021-09-13 · brand METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Metoprolol-L: Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92649 · Verify on the e-Formulary ↗ (DIN 02442132)

Source record
DIN 02442132: Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id SIV Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02442132 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92649
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol · DIN 00618640 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: resolved shortage (ended 2025-07-11); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02442132
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PMS-Metoprolol-L · DIN 02230804 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Metoprolol-L · DIN 02230804 Manufacturer: Pharmascience Inc.; listing date 1998-12-31 Daily cost (source): $0.2722 Health Canada: Marketed since 1998-04-16 · brand PMS-METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Metoprolol-L: Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50068 · Verify on the e-Formulary ↗ (DIN 02230804)

Source record
DIN 02230804: PMS-Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id PMS Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02230804 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50068
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol · DIN 00618640 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 Metoprolol-L · DIN 02442132 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: resolved shortage (ended 2018-03-23); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02230804
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Metoprolol · DIN 00648043 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Metoprolol · DIN 00648043 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $0.2722 Health Canada: Marketed since 2011-01-25 · brand TEVA-METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Metoprolol: Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6612 · Verify on the e-Formulary ↗ (DIN 00648043)

Source record
DIN 00648043: Teva-Metoprolol Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id TEV Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00648043 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6612
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol · DIN 00618640 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 Metoprolol-L · DIN 02442132 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: resolved shortage (ended 2025-12-03); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00648043
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Metoprolol (Uncoated) · DIN 00842656 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Metoprolol (Uncoated) · DIN 00842656 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $0.2722 Health Canada: Marketed since 2011-01-25 · brand TEVA-METOPROLOL · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Metoprolol (Uncoated): Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9887 · Verify on the e-Formulary ↗ (DIN 00842656)

Source record
DIN 00842656: Teva-Metoprolol (Uncoated) Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id TEV Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00842656 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9887
Interchangeable products
AG-Metoprolol-L · DIN 02481324 · $0.1361 Apo-Metoprolol · DIN 00618640 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 Metoprolol-L · DIN 02442132 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361
Shortage status: discontinued (2016-07-04, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00842656
Shortage record checked 2026-09-13T08:10:21.292534+00:00

AG-Metoprolol-L · DIN 02481316 · 50mg · tablet

General benefitDormant since 2025-07-30 · checked 2026-09-02 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
AG-Metoprolol-L · DIN 02481316 Manufacturer: Angita Pharma Inc.; listing date 2020-11-30 Daily cost (source): $0.1248 Health Canada: Dormant since 2025-07-30 · brand AG-METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Angita pharma inc. · schedule Prescription
Check this DIN again · Health Canada product record

AG-Metoprolol-L: Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97180 · Verify on the e-Formulary ↗ (DIN 02481316)

Source record
DIN 02481316: AG-Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id ANG Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02481316 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97180
Interchangeable products
Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02481316
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2025-07-30 — choose a marketed DIN from the same-category list.

AG-Metoprolol-L · DIN 02481324 · 100mg · tablet

General benefitDormant since 2025-07-30 · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
AG-Metoprolol-L · DIN 02481324 Manufacturer: Angita Pharma Inc.; listing date 2020-11-30 Daily cost (source): $0.2722 Health Canada: Dormant since 2025-07-30 · brand AG-METOPROLOL-L · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Angita pharma inc. · schedule Prescription
Check this DIN again · Health Canada product record

AG-Metoprolol-L: Formulary list price $0.1361/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1361 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97181 · Verify on the e-Formulary ↗ (DIN 02481324)

Source record
DIN 02481324: AG-Metoprolol-L Raw flags: chronicUseMed=Y, sec3=Y Item: 240400036; group id 284; item number 0608; lccId None; manufacturer id ANG Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1361; ministry $0.1361 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02481324 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97181
Interchangeable products
Apo-Metoprolol · DIN 00618640 · $0.1361 Apo-Metoprolol (Type L) · DIN 00751170 · $0.1361 Betaloc · DIN 00402540 · not recorded Jamp-Metoprolol-L · DIN 02356848 · $0.1361 Lopresor · DIN 00397431 · not recorded Metoprolol · DIN 02350408 · $0.1361 Metoprolol-L · DIN 02442132 · $0.1361 PMS-Metoprolol-L · DIN 02230804 · $0.1361 Sandoz Metoprolol (Type L) · DIN 02354195 · $0.1361 Teva-Metoprolol · DIN 00648043 · $0.1361 Teva-Metoprolol (Uncoated) · DIN 00842656 · $0.1361
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02481324
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2025-07-30 — choose a marketed DIN from the same-category list.

AA-Metoprolol SR · DIN 02285177 · 200mg · LA tablet

General benefitDormant since 2022-10-13 · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
AA-Metoprolol SR · DIN 02285177 Manufacturer: A A Pharma Inc.; listing date 2007-11-10 Health Canada: Dormant since 2022-10-13 · brand AA-METOPROLOL SR · ATC C07AB02 METOPROLOL · form Tablet (extended-release) · route Oral · ingredients METOPROLOL TARTRATE 200 MG · company Aa pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

AA-Metoprolol SR: Formulary list price $0.2568/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2568 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77068 · Verify on the e-Formulary ↗ (DIN 02285177)

Source record
DIN 02285177: AA-Metoprolol SR Raw flags: chronicUseMed=Y, sec3=Y Item: 240400044; group id 284; item number 0606; lccId None; manufacturer id AAP Source form: LA Tab; strength: 200mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2568; ministry $0.2568 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02285177 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77068
Interchangeable products
Lopresor SR · DIN 00534560 · not recorded
Shortage status: active shortage (reported 2015-08-07, last updated 2017-10-05) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02285177
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2022-10-13 — choose a marketed DIN from the same-category list.

Sandoz Metoprolol (Type L) · DIN 02354187 · 50mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2018-08-01 — choose a marketed DIN from the same-category list.Discontinued 2018-08-01 · checked 2026-09-02
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2018-08-01 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2018-08-01 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Metoprolol (Type L) · DIN 02354187 Manufacturer: Sandoz Canada Inc.; listing date 2011-03-15 Daily cost (source): $0.1248 Health Canada: Cancelled post market since 2018-08-01 · brand SANDOZ METOPROLOL (TYPE L) · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Sandoz canada incorporated · schedule Prescription
Check this DIN again · Health Canada product record

Sandoz Metoprolol (Type L): Formulary list price $0.0624/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0624 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83938 · Verify on the e-Formulary ↗ (DIN 02354187)

Source record
DIN 02354187: Sandoz Metoprolol (Type L) Raw flags: chronicUseMed=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id SDZ Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.0624; ministry $0.0624 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02354187 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83938
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02354187
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2018-08-01 — choose a marketed DIN from the same-category list.

Betaloc · DIN 00402605 · 50mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-12-15 — choose a marketed DIN from the same-category list.Discontinued 2009-12-15 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-12-15 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2009-12-15 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Betaloc · DIN 00402605 Manufacturer: AstraZeneca; listing date 1996-10-01 Daily cost (source): $0.1248 Health Canada: Cancelled post market since 2009-12-15 · brand BETALOC TAB 50 MG · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Astrazeneca canada inc · schedule Prescription
Check this DIN again · Health Canada product record

Betaloc: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3001 · Verify on the e-Formulary ↗ (DIN 00402605)

Source record
DIN 00402605: Betaloc Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id AZC Source form: Tab; strength: 50mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00402605 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3001
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Lopresor · DIN 00397423 · not recorded Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00402605
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2009-12-15 — choose a marketed DIN from the same-category list.

Lopresor · DIN 00397423 · 50mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2019-08-14 — choose a marketed DIN from the same-category list.Discontinued 2019-08-14 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2019-08-14 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2019-08-14 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Lopresor · DIN 00397423 Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-10-01 Daily cost (source): $0.1248 Health Canada: Cancelled post market since 2019-08-14 · brand LOPRESOR 50MG · ATC C07AB02 METOPROLOL · form Tablet · route Oral · ingredients METOPROLOL TARTRATE 50 MG · company Novartis pharmaceuticals canada inc · schedule Prescription
Check this DIN again · Health Canada product record

Lopresor: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2738 · Verify on the e-Formulary ↗ (DIN 00397423)

Source record
DIN 00397423: Lopresor Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240400037; group id 284; item number 0607; lccId None; manufacturer id NOV Source form: Tab; strength: 50mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00397423 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2738
Interchangeable products
AG-Metoprolol-L · DIN 02481316 · $0.0624 Apo-Metoprolol · DIN 00618632 · $0.0624 Apo-Metoprolol (Type L) · DIN 00749354 · $0.0624 Betaloc · DIN 00402605 · not recorded Jamp-Metoprolol-L · DIN 02356821 · $0.0624 Metoprolol · DIN 02350394 · $0.0624 Metoprolol-L · DIN 02442124 · $0.0624 PMS-Metoprolol-L · DIN 02230803 · $0.0624 Sandoz Metoprolol (Type L) · DIN 02354187 · $0.0624 Teva-Metoprolol · DIN 00648035 · $0.0624 Teva-Metoprolol (Uncoated) · DIN 00842648 · $0.0624
Shortage status: discontinued (2018-04-19, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00397423
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2019-08-14 — choose a marketed DIN from the same-category list.

Lopresor SR · DIN 00658855 · 100mg · LA tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2021-10-21 — choose a marketed DIN from the same-category list.Discontinued 2021-10-21 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2021-10-21 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2021-10-21 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Lopresor SR · DIN 00658855 Manufacturer: Novartis Pharma Canada Inc.; listing date 2001-10-11 Health Canada: Cancelled post market since 2021-10-21 · brand LOPRESOR SR 100MG · ATC C07AB02 METOPROLOL · form Tablet (extended-release) · route Oral · ingredients METOPROLOL TARTRATE 100 MG · company Novartis pharmaceuticals canada inc · schedule Prescription
Check this DIN again · Health Canada product record

Lopresor SR: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6311 · Verify on the e-Formulary ↗ (DIN 00658855)

Source record
DIN 00658855: Lopresor SR Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240400069; group id 284; item number 0605; lccId None; manufacturer id NOV Source form: LA Tab; strength: 100mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00658855 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6311
Interchangeable products
AA-Metoprolol SR · DIN 02285169 · $0.2058
Shortage status: discontinued (2020-11-19, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00658855
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2021-10-21 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (24:04 Cardiac Drugs) and how they are covered

Matched class: 24:04 Cardiac Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ATENOLOL, DIGOXIN, PROPAFENONE HCL Some products covered without a code (check the product listing): ACEBUTOLOL HCL, AMIODARONE HCL, AMLODIPINE, BISOPROLOL FUMARATE, DILTIAZEM HCL, DISOPYRAMIDE, FLECAINIDE ACETATE, MEXILETINE HCL, NADOLOL, NIFEDIPINE, PROPRANOLOL, SOTALOL HCL, TIMOLOL MALEATE, VERAPAMIL HCL 24:00 CARDIOVASCULAR DRUGS

RANOLAZINE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · ER Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:00 24:04 Cardiac Drugs

ACEBUTOLOL HCL

· 9 products · Listed, not a benefit (3), General benefit (6) · strengths: 100mg, 200mg, 400mg · Tab

ATENOLOL

· 26 products · General benefit · strengths: 50mg, 100mg · Tab

BISOPROLOL FUMARATE

· 20 products · General benefit (18), Listed, not a benefit (2) · strengths: 1.25mg, 2.5mg, 5mg, 10mg · Tab

NEBIVOLOL HYDROCHLORIDE

· 8 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

NADOLOL

· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 40mg, 80mg, 160mg · Tab

PROPRANOLOL

· 19 products · Off-Formulary Interchangeable, not an ODB benefit (8), General benefit (7), Listed, not a benefit (4) · strengths: 60mg, 80mg, 120mg, 160mg, 10mg, 20mg, 40mg · LA Cap, Tab

SOTALOL HCL

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 80mg, 160mg · Tab

TIMOLOL MALEATE

· 6 products · Listed, not a benefit (3), General benefit (3) · strengths: 5mg, 10mg, 20mg · Tab

CARVEDILOL

· 36 products · Listed, not a benefit (4), Limited Use, codes 183 (32) · strengths: 3.125mg, 6.25mg, 12.5mg, 25mg · Tab

AMIODARONE HCL

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 200mg · Tab

AMLODIPINE

· 56 products · Limited Use, codes 645, 706 (1), Off-Formulary Interchangeable, not an ODB benefit (11), General benefit (44) · strengths: 1mg/mL, 2.5mg, 5mg, 10mg · Oral Sol, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:04 and 9 more
Full class listing Related classes: 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: or hypertension
From Health Canada product monographs; label wording only, not a treatment recommendation. Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ. Covered without a code on the Ontario formulary: ATENOLOL ATENOLOL · General benefit 1 INDICATIONS APO-ATENOL (atenolol) is indicated for: • patients with mild or moderate hypertension. PM: https://pdf.hres.ca/dpd_pm/00074716.PDF; date February 2, 2024; DIN 00773689; fetched 2026-09-10 Product monograph Coverage source: ON formulary extract 2026-08-26
What the Health Canada label says it is for
1 INDICATIONS Hypertension APO-METOPROLOL / APO-METOPROLOL (Type L) (metoprolol tartrate) is indicated for mild or moderate hypertension. Usually combined with other antihypertensive agents (thiazide diuretics), it may be tried alone when the physician judges that a beta-blocker, rather than a diuretic, should be the initial treatment. Combining metoprolol tartrate with a diuretic or peripheral vasodilator has been found to be compatible and generally more effective than metoprolol tartrate alone. Limited experience with other antihypertensive agents has not shown evidence of incompatibility with metoprolol tartrate. APO-METOPROLOL / APO-METOPROLOL (Type L) is not recommended for the emergency treatment of hypertensive crises. Angina Pectoris APO-METOPROLOL / APO-METOPROLOL (Type L) is indicated for the long-term treatment of angina pectoris due to ischemic heart disease. Myocardial Infarction APO-METOPROLOL / APO-METOPROLOL (Type L) is indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction, to reduce cardiovascular mortality. In patients with proven myocardial infarction, oral treatment can begin within 3 t… https://pdf.hres.ca/dpd_pm/00085409.PDF PM date: JUL 10, 2026 Source product: APO-METOPROLOL; DIN 00618632; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Jamp-Metoprolol-L · DIN 02356821 Shortage status: active shortage (reported 2024-01-12, estimated to end 2026-12-31, last updated 2026-05-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02356821

Check this DIN again

Metoprolol · DIN 02350394 Shortage status: active shortage (reported 2025-09-03, last updated 2025-09-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02350394

Check this DIN again

Jamp-Metoprolol-L · DIN 02356848 Shortage status: active shortage (reported 2024-01-12, estimated to end 2026-12-31, last updated 2026-05-05); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02356848

Check this DIN again

Teva-Metoprolol (Uncoated) · DIN 00842656 Shortage status: discontinued (2016-07-04, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00842656

Check this DIN again

AA-Metoprolol SR · DIN 02285177 Shortage status: active shortage (reported 2015-08-07, last updated 2017-10-05) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02285177

Check this DIN again

Lopresor · DIN 00397423 Shortage status: discontinued (2018-04-19, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00397423

Check this DIN again

Lopresor SR · DIN 00658855 Shortage status: discontinued (2020-11-19, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00658855

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For Betaloc, Lopresor, Lopresor SR: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026